ARUP's Laboratory Test Directory
| 0081312: Des-gamma-carboxy Prothrombin |
| Test Mnemonic: DCP | |
|
#ExistMethodology>
Methodology: Liquid-Phase Binding Immunoassay
*ExistMethodology> #ExistPerformed> Performed: Tue *ExistPerformed> #ExistReported> Reported: 1-8 days *ExistReported> |
| Specimen Required: | |
|
#ExistCollect>
Collect: One 3 mL red or SST.
*ExistCollect> #ExistTransport> Transport: 1 mL serum at 2-8°C. (Min: 0.5 mL) Submit specimen in an ARUP Standard Transport Tube. *ExistTransport> #ExistPedCollectTransport> Pediatric Collection/Transport: 0.5 mL serum at 2-8°C. *ExistPedCollectTransport> #ExistRemarks> Remarks: Separate from cells ASAP. Avoid repeated freeze/thaw cycles. *ExistRemarks> #ExistConditions> Unacceptable Conditions: Plasma. *ExistConditions> #ExistStability> Stability: After separation from cells: Ambient: 2 days; Refrigerated: 1 week; Frozen: 3 months *ExistStability> |
|
| Reference Interval: |
| #ExistRefRange> 0.0-7.4 ng/mL *ExistRefRange> |
| Interpretive Data: | |
|
#ExistInterpData>
The Wako LiBASysmethod is used. Results obtained with different assay methods or kits cannot be used interchangeably. The Wako Des-gamma-carboxy Prothrombin (DCP) assay is intended as a risk assessment test for the development of hepatocellular carcinoma in patients with chronic liver diseases. Elevated DCP values have been shown to be associated with an increased risk of developing hepatocellular carcinoma. Patients with elevated serum DCP should be more intensely evaluated for evidence of hepatocellular carcinoma.
*ExistInterpData> |
| CPT Code(s): | |
| 86316 |